VIDEO: The evolving AMD treatment landscape

Editor’s note: This is an automatically generated transcript. Please notify editor@healio.com if there are concerns regarding accuracy of the transcription.

The current treatment landscape for AMD is primarily focused around exudative macular degeneration. And most recently, we've had FDA approval of faricimab, which has allowed for a greater drying as well as durability for our patients with exudative macular degeneration. I think this has really offered patients a wonderful opportunity to maybe have increased spacing between the visits. And I think that's great not only for the patient but also for the caretakers of the patients.